Endexx signs definitive agreement to acquire THCFinder.com and Herbal Care

NewsGuard 100/100 Score

Endexx Corporation (OTC Pink: EDXC) is pleased to announce it has entered into a definitive agreement to acquire THCFinder.com and its parent company Herbal Care LLC. THCFinder.com is a leading player in Social Media and Cultural content in the Medical Marijuana industry, providing both relevant content and educational material to its user base related to the Medical Marijuana arena. The company is, dedicated to helping legal patients find access to safe, secure businesses with the most respectable reputations.

Todd Davis, CEO Endexx, stated "Endexx is excited to partner with and support the long term growth of this addition to the M3Hub™. Ruben Granados and his team have created a robust platform supporting legal marijuana patients across the country. This is an extremely dynamic revenue model that offers tremendous upside growth and profit margins to the M3Hub platform." THCFinder.com has grown a vast following in this sector averaging 15-20 thousand hits daily to the website and over 2 million visits per month.  There are over 80 thousand registered users and more than 200,000 followers on their social media profiles. While averaging between 1000 and 2000 app downloads a day the company has positioned itself as an established leader in the industry.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.